African trypanosomiasis is a parasitic disease that affects both humans and animals. This study investigated the antitrypanosomal activities of crude and an alkaloidal fraction of Diospyros mespiliformis in Trypanosoma evansi – infected rats. A total of twenty-one (21) albino rats were infected with Trypanosoma evansi and grouped into seven (A-G) of 3 rats each. Group A serve as normal control, groups B and C were given 0.2 ml normal saline/kg BW and 3.5 mg/kg BW diminazene aceturate respectively, groups D and E were treated with 100 and 200 mg/kg BW alkaloidal while groups E and F received crude extract at 200 and 400 mg/kg respectively for twelve days. Results revealed that both crude and an alkaloidal fraction of D. mespiliformis exhibited significant (p<0.05) dose-dependent antitrypanosomal activities. The crude extract exhibited 54.55±3.04 % (200 mg/kg BW) and 66.02±5.03 (200 mg/kg BW) curative effect while the alkaloidal fraction exhibited better antitrypanosomal activities with 68.68±2.34 % and 70.87±2.93 curative effect at 100 and 200 mg/kg respectively. Furthermore, the crude extract prolonged the survival of the animals to 19.02±2.06 (200 mg/kg BW) and 22.90±3.78 (400 mg/kg BW) while the alkaloidal fraction at 100 and 200 mg/kg prolonged the survival of the mice to 23.45±1.24 and 29.34±3.45 days respectively and improved the body weight gain of the animals when compared with the non-treated control (13.24±1.33 days). In conclusion, the leaves of Diospyros mespiliformis could be employed for the treatment of T. evansi infection as an alternative to conventional medicines that are besieged with undesirable properties
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.